What is InnAccel?
InnAccel Technologies Pvt Ltd is a pioneering force in the healthcare technology sector, dedicated to developing and deploying advanced medical devices that address critical needs, particularly in underserved markets. The company's innovative product portfolio includes the VAPCARE automated secretion management system, the AI-powered Fetal Lite fetal heart rate monitor, and the SAANS portable neonatal CPAP device. InnAccel's strategic focus on enhancing healthcare accessibility through technology, often in collaboration with NGOs and government initiatives, positions it as a key player in improving health outcomes globally, with a strong emphasis on the Indian market.
How much funding has InnAccel raised?
InnAccel has raised a total of $1.5M across 1 funding round:
Other Financing Round
$1.5M
Other Financing Round (2020): $1.5M with participation from A Vijayarajan, Siraj Dhanani, and Mount Judi Ventures
Key Investors in InnAccel
A Vijayarajan
A Vijayarajan is an individual investor who has participated in InnAccel's funding rounds, indicating a personal interest in the company's mission and technological advancements in healthcare.
Siraj Dhanani
Siraj Dhanani is an individual investor contributing to InnAccel's growth, likely recognizing the company's innovative approach to addressing critical healthcare challenges.
Mount Judi Ventures
Mount Judi Ventures is an investment entity that has backed InnAccel, suggesting a strategic focus on companies with high-impact potential in the technology and healthcare sectors.
What's next for InnAccel?
With the recent infusion of capital, InnAccel is poised for accelerated growth and expanded deployment of its life-saving medical technologies. The company's trajectory suggests a focus on scaling its operations, further research and development into novel healthcare solutions, and strengthening its market presence both domestically and internationally. This strategic investment will likely enable InnAccel to deepen its impact in improving healthcare access and outcomes, solidifying its reputation as an innovator in medical technology.
See full InnAccel company page
